Jaipur | A major controversy involving alleged financial misconduct and illegal pharmaceutical operations at a private hospital in Rajasthan’s capital Jaipur has triggered serious concerns over healthcare regulation, drug monitoring and financial transparency. Authorities have arrested Manish Kumar Soni, a medical assistant employed at a private hospital located on Gopalpura Bypass, in connection with allegations of embezzlement worth nearly ₹80 lakh to ₹90 lakh and the illegal sale of so-called “sex power” injections. The case has drawn the attention of multiple investigative agencies after allegations surfaced involving unauthorised drug distribution, suspicious financial transactions and possible destruction of records.
The investigation began after the hospital administration lodged a complaint with the cyber police station. According to the complaint, the accused allegedly diverted money earned from the sale of medicines into his personal bank account instead of depositing the amount into the hospital’s authorised account. Preliminary scrutiny reportedly revealed suspicious financial transactions involving lakhs of rupees, following which police detained the accused for questioning.
FCRF Academy Launches Premier Anti-Money Laundering Certification Program
During the probe, investigators uncovered details related to an alleged illegal injection marketed under the name “Trimix.” Officials claim that the injection had been sold for several years as a performance-enhancing or “sex power” medication. Investigators suspect that the product was created by mixing three separate medicines and was then marketed at premium prices to customers. Authorities believe the network was not limited to Rajasthan or even India, as the injections were allegedly supplied to multiple states and even shipped overseas through online orders and private distribution channels.
One of the most serious allegations in the case is that the so-called “Trimix” injection reportedly did not have approval from the Drug Controller General of India (DCGI). Despite lacking regulatory clearance, investigators believe the product continued to be sold for an extended period. Experts warn that the unauthorised sale of injectable drugs without medical approval can pose significant risks to public health and patient safety.
Investigators have also flagged the use of a name called “Oh Man Pharmacy” in the alleged transactions. According to officials, invoices for the injections were generated under this name, but preliminary verification reportedly found no registered pharmacy or licensed medical firm operating under that identity. Authorities suspect that an unlicensed pharmaceutical distribution network may have been functioning for years without proper oversight. Digital payment trails, banking records and online order details are now being treated as crucial evidence in the investigation.
Sources associated with the probe claim that once the hospital administration became aware of possible regulatory action, stocks of the injections and several related records were allegedly removed from the premises. Investigating agencies suspect that sales registers, transaction records and supply documents may have been deliberately destroyed or concealed. However, officials say financial activities are still being reconstructed using banking data and digital transaction histories.
According to available information, the Rajasthan Drugs Control Department intensified scrutiny after receiving inputs from the Gujarat Drugs Department regarding the alleged supply of unauthorised injections. A raid was conducted at the hospital on April 9, 2026. Authorities now suspect that the sale and distribution of unapproved injections had been taking place for a long period. Reports regarding the matter have also been forwarded to the Drug Controller General of India and the Rajasthan Medical Council for further action.
Renowned cyber crime expert and former IPS officer Prof. Triveni Singh said the case highlights how weak oversight in digital payments and online supply systems can create opportunities for financial and medical irregularities. According to him, “When hospitals and healthcare institutions lack strong monitoring mechanisms for medicine sales, digital transactions and supply chains, such networks can continue operating unnoticed for years. Regular audits, digital tracking and strict regulatory supervision are essential to prevent such cases.”
Experts believe that if the allegations are substantiated, the matter may extend far beyond embezzlement and could involve serious charges related to illegal drug distribution, unlicensed medical trade, financial fraud and threats to public health safety. Police, drugs control authorities and other agencies are currently conducting a detailed investigation into the hospital administration, financial records and the suspected supply network linked to the case.
